Related Experiment Video
Updated: Oct 13, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Vitamin Status as Predictors in Rheumatoid Arthritis
Radu Razvan Mititelu1, Manuela Violeta Bacanoiu2, Ana-Maria Buga3
1Department of Microbiology, University of Medicine and Pharmacy of Craiova, Romania.
Elevated homocysteine (Hcy) levels and C-reactive protein (CRP) predict complications in Rheumatoid arthritis (RA) patients. Folic acid and vitamin B12 supplements are crucial for managing RA patients, potentially reducing risks.
Area of Science:
- Rheumatology
- Clinical Biochemistry
- Nutritional Science
Background:
- Musculoskeletal disorders, including Rheumatoid Arthritis (RA), are a major cause of disability in the EU, incurring substantial healthcare costs.
- Current RA diagnosis relies on clinical criteria, lacking specific biomarkers to differentiate disease patterns or predict complications.
- Vitamin deficiencies associated with chronic inflammation may influence disease progression and complication risk in RA patients.
Purpose of the Study:
- To investigate the correlation between homocysteine (Hcy) levels in Rheumatoid Arthritis (RA) patients and their clinical status.
- To determine if Hcy levels can serve as a predictive biomarker for complications in RA patients undergoing treatment with disease-modifying antirheumatic drugs (DMARDs).
- To assess the role of folic acid and vitamin B12 supplementation in managing RA and associated risks.
Main Methods:
- Analysis of peripheral blood samples from RA patients to measure homocysteine (Hcy) levels.
- Correlation analysis between Hcy levels, C-reactive protein (CRP) levels, and clinical indicators of inflammation and disease activity.
- Evaluation of the impact of folic acid and vitamin B12 supplementation on RA patient outcomes.
Main Results:
- Plasma Hcy levels and CRP were identified as independent predictors of chronic inflammatory status in RA patients.
- Elevated Hcy levels are associated with an increased risk of complications in RA patients.
- Folic acid and vitamin B12 supplements were found to be important in the management of RA patients.
Conclusions:
- Hcy and CRP are valuable biomarkers for assessing the chronic inflammatory status and predicting complication risk in RA patients.
- Monitoring Hcy levels and ensuring adequate vitamin B12 and folic acid status are crucial for optimizing RA management.
- Further research into the role of vitamin supplementation may clarify its impact on cardiovascular event risk in RA.
Related Concept Videos
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management

